ch.oddb.org
 
Apotheken | Doctor | Drugs | Hospital | Interactions | MiGeL | Registration owner | Services
Information for professionals for DANTROLEN i.v.:Norgine AG
Complete information for professionalsDDDÄnderungen anzeigenPrint 
Composition.Galenic FormIndication.UsageContra IndicationWarning restrictions.Interactions.Pregnancy
Driving abilityUnwanted effectsOverdoseEffectsPharm.kinetikPreclinicalOther adviceSwissmedic-Nr.
PackagesRegistration ownerLast update of information 
M03CA01 - DantroleneATC-DDD Version 2016. Source: WHO
M - Musculo-Skeletal System
 
M03 - Muscle Relaxants

This group comprises peripherally, centrally and directly acting muscle relaxants.
See also G04BD - Drugs for urinary frequency and incontinence.

M03C - Muscle Relaxants, Directly Acting Agents

This group comprises agents acting directly on the muscles such as dantrolene.

M03CA - Dantrolene and Derivatives
 

The DDD of dantrolene is based on the treatment of spasticity after spinal injury.

M03CA01 - Dantrolene
DoseRoute of administrationNote
 O 
2025 ©ywesee GmbH
Settings | Help | FAQ | Login | Contact | Home